John­son & John­son dri­ves pe­riph­er­al artery dis­ease aware­ness in new ‘Save Legs’ ini­tia­tive

Spurred by new claims da­ta, John­son & John­son’s Janssen is launch­ing a “ro­bust in­ter­ven­tion” around pe­riph­er­al artery dis­ease (PAD). The new “Save Legs. Change Lives …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER